When, if ever, is parametric release of Intermediates allowed, either to skip testing or reduce testing? 951 viewsOctober 10, 2022DrugsPharmaceutical 0 Sam Smith11.38K October 2, 2020 0 Comments Spread the loveSpread the love 1 Answer ActiveVotedNewestOldest 0 Blogolu28.38K Posted October 2, 2020 0 Comments Spread the loveIf parametric or skip lot testing is in compliance with the registration and allows compliance with the intent of Q7A, there is nothing in Q7A that prohibits either parametric release or skip lot testing. Spread the love You are viewing 1 out of 1 answers, click here to view all answers. Login